Clinical Trials Browser

Phase 1/2 × talimogene laherparepvec × Dermatologic × Clear all

NCT01740297 2024-05-14

Ipilimumab With or Without Talimogene Laherparepvec in Unresected Melanoma

Phase 1/2 Completed

217 enrolled 27 charts

Melanoma

NCT03555032 2021-08-18

TITAN

Phase 1/2 Completed

DermatologicSarcoma

Melanoma, Sarcoma